tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Compare Mineralys Therapeutics, Inc. (MLYS) vs. Competitors

Compare
585 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$30.89
$2.44B
200.78%
6 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$29.04
$3.28B
-13.71
-13.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$41.01
$3.17B
-10.56
1.33%
14 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$22.58
$2.86B
76.05
-25.70%
10 Buy
6 Hold
0 Sell
Moderate Buy
NewAmsterdam Pharma Company
$31.12
$3.53B
-15.24
42.95%
9 Buy
1 Hold
0 Sell
Strong Buy
Centessa Pharmaceuticals
$24.57
$3.30B
-13.50
45.30%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
30.89
20.96
211.08%
VKTX
Viking Therapeutics
29.04
-2.48
-7.87%
XENE
Xenon
41.01
1.46
3.69%
APLS
Apellis Pharmaceuticals
22.58
-5.91
-20.74%
NAMS
NewAmsterdam Pharma Company
31.12
9.76
45.69%
CNTA
Centessa Pharmaceuticals
24.57
7.67
45.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts